BCGM Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BCGM Wealth Management's LLY Position: Q2 2026 in Review
BCGM Wealth Management increased its Eli Lilly (LLY) stake by 82% in Q2 2026, buying an estimated $4.12M and bringing the position to 8,946 shares worth $10.7M. The position accounts for 2.27% of the portfolio, ranked #9.
BCGM Wealth Management first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- BCGM Wealth Management held 8,946 shares of Eli Lilly worth $10.7M as of Q2 2026.
- BCGM Wealth Management bought 4,037 Eli Lilly shares in Q2 2026, an estimated $4.12M.
- Eli Lilly made up 2.27% of BCGM Wealth Management's portfolio in Q2 2026, its #9 holding.
- BCGM Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
- 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on BCGM Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.